Webinar - COVID Vaccines Immunity and Variants - POCTRN
Center news
Webinar - COVID Vaccines: Immunity and Variants
The COVID-19 pandemic has claimed an estimated 15 million lives, including more than 1 million lives in the United States alone. The rapid development of multiple COVID-19 vaccines has been a triumph of biomedical research, and billions of vaccine doses have been administered worldwide. Join this webinar to learn about the current state of knowledge about immune responses to COVID-19 vaccines and the importance of both humoral and cellular immunity for durable protection against severe disease.
When:
February 14th
2PM ET
Speaker:
Dan Barouch, M.D., Ph.D.
William Bosworth Castle Professor of Medicine
Harvard Medical School
Ragon Institute of MGH, MIT, and Harvard
Director, Center for Virology and Vaccine Research
Beth Israel Deaconess Medical Center
RADx: Rapid Acceleration of Diagnostics
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADx®) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
In the News
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
The National Strategy From the COVID-19 Response and Pandemic Preparedness